APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pneumococcal Bacteria Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pneumococcal Bacteria Vaccine Industry Growth and Trends Forecast to 2032

2 January 202695 pages

Choose your research edition.

Industry ResearchPneumococcal Bacteria Vaccine Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Pneumococcal Bacteria Vaccine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Pneumococcal Bacteria Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pneumococcal Bacteria Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pneumococcal Bacteria Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pneumococcal Bacteria Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pneumococcal Bacteria Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pneumococcal Bacteria Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pneumococcal Bacteria Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pneumococcal Bacteria Vaccine include Sanofi, Merck, Pfizer, GSK, Walvax and Sinopharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pneumococcal Bacteria Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pneumococcal Bacteria Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pneumococcal Bacteria Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pneumococcal Bacteria Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pneumococcal Bacteria Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pneumococcal Bacteria Vaccine Market by Company

Sanofi

Merck

Pfizer

GSK

Walvax

Sinopharm

Pneumococcal Bacteria Vaccine Segment by Type

PPSV 23

PCV 13

PCV 10

Pneumococcal Bacteria Vaccine Segment by Application

Infant

Children

Adult

Pneumococcal Bacteria Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Bacteria Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Bacteria Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Bacteria Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pneumococcal Bacteria Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pneumococcal Bacteria Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of PPSV 23 Table 2. Major Company of PCV 13 Table 3. Major Company of PCV 10 Table 4. Global Pneumococcal Bacteria Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (K Doses) Table 6. Global Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Pneumococcal Bacteria Vaccine Sales Market Share in Value by Type (2021-2026) Table 9. Global Pneumococcal Bacteria Vaccine Price by Type (2021-2026) & (US$/Dose) Table 10. Global Pneumococcal Bacteria Vaccine Sales by Type (2027-2032) & (K Doses) Table 11. Global Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Pneumococcal Bacteria Vaccine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Pneumococcal Bacteria Vaccine Sales Market Share in Value by Type (2027-2032) Table 14. Global Pneumococcal Bacteria Vaccine Price by Type (2027-2032) & (US$/Dose) Table 15. North America Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (K Doses) Table 16. North America Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (K Doses) Table 18. Europe Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (K Doses) Table 20. Asia-Pacific Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (K Doses) Table 22. Latin America Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (K Doses) Table 24. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Pneumococcal Bacteria Vaccine Industry Trends Table 26. Pneumococcal Bacteria Vaccine Industry Drivers Table 27. Pneumococcal Bacteria Vaccine Industry Opportunities and Challenges Table 28. Pneumococcal Bacteria Vaccine Industry Restraints Table 29. Global Pneumococcal Bacteria Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Company (2021-2026) Table 31. Global Pneumococcal Bacteria Vaccine Sales by Company (2021-2026) & (K Doses) Table 32. Global Pneumococcal Bacteria Vaccine Sales Share by Company (2021-2026) Table 33. Global Pneumococcal Bacteria Vaccine Market Price by Company (2021-2026) & (US$/Dose) Table 34. Global Pneumococcal Bacteria Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Pneumococcal Bacteria Vaccine Major Company Production Sites and Headquarters Table 36. Global Pneumococcal Bacteria Vaccine Company, Product Type & Application Table 37. Global Pneumococcal Bacteria Vaccine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Pneumococcal Bacteria Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Pneumococcal Bacteria Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Pneumococcal Bacteria Vaccine Sales by Region (2021-2026) & (K Doses) Table 42. Global Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Pneumococcal Bacteria Vaccine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Pneumococcal Bacteria Vaccine Sales Market Share in Value by Region (2021-2026) Table 45. Global Pneumococcal Bacteria Vaccine Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 46. Global Pneumococcal Bacteria Vaccine Sales by Region (2027-2032) & (K Doses) Table 47. Global Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Pneumococcal Bacteria Vaccine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Pneumococcal Bacteria Vaccine Sales Market Share in Value by Region (2027-2032) Table 50. Global Pneumococcal Bacteria Vaccine Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2027-2032) Table 51. Global Pneumococcal Bacteria Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (K Doses) Table 53. Global Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Pneumococcal Bacteria Vaccine Sales Market Share in Value by Application (2021-2026) Table 56. Global Pneumococcal Bacteria Vaccine Price by Application (2021-2026) & (US$/Dose) Table 57. Global Pneumococcal Bacteria Vaccine Sales by Application (2027-2032) & (K Doses) Table 58. Global Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Pneumococcal Bacteria Vaccine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Pneumococcal Bacteria Vaccine Sales Market Share in Value by Application (2027-2032) Table 61. Global Pneumococcal Bacteria Vaccine Price by Application (2027-2032) & (US$/Dose) Table 62. North America Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (K Doses) Table 63. North America Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (K Doses) Table 65. Europe Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (K Doses) Table 67. Asia-Pacific Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (K Doses) Table 69. Latin America Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (K Doses) Table 71. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Pneumococcal Bacteria Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 75. Sanofi Pneumococcal Bacteria Vaccine Product Portfolio Table 76. Sanofi Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Pneumococcal Bacteria Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 80. Merck Pneumococcal Bacteria Vaccine Product Portfolio Table 81. Merck Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Pneumococcal Bacteria Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 85. Pfizer Pneumococcal Bacteria Vaccine Product Portfolio Table 86. Pfizer Recent Development Table 87. GSK Company Information Table 88. GSK Business Overview Table 89. GSK Pneumococcal Bacteria Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 90. GSK Pneumococcal Bacteria Vaccine Product Portfolio Table 91. GSK Recent Development Table 92. Walvax Company Information Table 93. Walvax Business Overview Table 94. Walvax Pneumococcal Bacteria Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 95. Walvax Pneumococcal Bacteria Vaccine Product Portfolio Table 96. Walvax Recent Development Table 97. Sinopharm Company Information Table 98. Sinopharm Business Overview Table 99. Sinopharm Pneumococcal Bacteria Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 100. Sinopharm Pneumococcal Bacteria Vaccine Product Portfolio Table 101. Sinopharm Recent Development Table 102. North America Pneumococcal Bacteria Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 103. North America Pneumococcal Bacteria Vaccine Sales by Country (2021-2026) & (K Doses) Table 104. North America Pneumococcal Bacteria Vaccine Sales Market Share by Country (2021-2026) Table 105. North America Pneumococcal Bacteria Vaccine Sales Forecast by Country (2027-2032) & (K Doses) Table 106. North America Pneumococcal Bacteria Vaccine Sales Market Share Forecast by Country (2027-2032) Table 107. North America Pneumococcal Bacteria Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. North America Pneumococcal Bacteria Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 109. North America Pneumococcal Bacteria Vaccine Market Share by Country (2021-2026) Table 110. North America Pneumococcal Bacteria Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. North America Pneumococcal Bacteria Vaccine Market Share Forecast by Country (2027-2032) Table 112. Europe Pneumococcal Bacteria Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 113. Europe Pneumococcal Bacteria Vaccine Sales by Country (2021-2026) & (K Doses) Table 114. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Country (2021-2026) Table 115. Europe Pneumococcal Bacteria Vaccine Sales Forecast by Country (2027-2032) & (K Doses) Table 116. Europe Pneumococcal Bacteria Vaccine Sales Market Share Forecast by Country (2027-2032) Table 117. Europe Pneumococcal Bacteria Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Europe Pneumococcal Bacteria Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 119. Europe Pneumococcal Bacteria Vaccine Market Share by Country (2021-2026) Table 120. Europe Pneumococcal Bacteria Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Europe Pneumococcal Bacteria Vaccine Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Pneumococcal Bacteria Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Pneumococcal Bacteria Vaccine Sales by Country (2021-2026) & (K Doses) Table 124. Asia-Pacific Pneumococcal Bacteria Vaccine Sales Market Share by Country (2021-2026) Table 125. Asia-Pacific Pneumococcal Bacteria Vaccine Sales Forecast by Country (2027-2032) & (K Doses) Table 126. Asia-Pacific Pneumococcal Bacteria Vaccine Sales Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Pneumococcal Bacteria Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Pneumococcal Bacteria Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 129. Asia-Pacific Pneumococcal Bacteria Vaccine Market Share by Country (2021-2026) Table 130. Asia-Pacific Pneumococcal Bacteria Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Asia-Pacific Pneumococcal Bacteria Vaccine Market Share Forecast by Country (2027-2032) Table 132. Latin America Pneumococcal Bacteria Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 133. Latin America Pneumococcal Bacteria Vaccine Sales by Country (2021-2026) & (K Doses) Table 134. Latin America Pneumococcal Bacteria Vaccine Sales Market Share by Country (2021-2026) Table 135. Latin America Pneumococcal Bacteria Vaccine Sales Forecast by Country (2027-2032) & (K Doses) Table 136. Latin America Pneumococcal Bacteria Vaccine Sales Market Share Forecast by Country (2027-2032) Table 137. Latin America Pneumococcal Bacteria Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Latin America Pneumococcal Bacteria Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 139. Latin America Pneumococcal Bacteria Vaccine Market Share by Country (2021-2026) Table 140. Latin America Pneumococcal Bacteria Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Latin America Pneumococcal Bacteria Vaccine Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Pneumococcal Bacteria Vaccine Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2021-2026) & (K Doses) Table 144. Middle East and Africa Pneumococcal Bacteria Vaccine Sales Market Share by Country (2021-2026) Table 145. Middle East and Africa Pneumococcal Bacteria Vaccine Sales Forecast by Country (2027-2032) & (K Doses) Table 146. Middle East and Africa Pneumococcal Bacteria Vaccine Sales Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Pneumococcal Bacteria Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Pneumococcal Bacteria Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 149. Middle East and Africa Pneumococcal Bacteria Vaccine Market Share by Country (2021-2026) Table 150. Middle East and Africa Pneumococcal Bacteria Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Middle East and Africa Pneumococcal Bacteria Vaccine Market Share Forecast by Country (2027-2032) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Pneumococcal Bacteria Vaccine Distributors List Table 155. Pneumococcal Bacteria Vaccine Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Pneumococcal Bacteria Vaccine Image Figure 2. Global Pneumococcal Bacteria Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pneumococcal Bacteria Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Pneumococcal Bacteria Vaccine Sales (2021-2032) & (K Doses) Figure 5. PPSV 23 Image Figure 6. Global PPSV 23 Sales YoY Growth (2021-2032) & (K Doses) Figure 7. PCV 13 Image Figure 8. Global PCV 13 Sales YoY Growth (2021-2032) & (K Doses) Figure 9. PCV 10 Image Figure 10. Global PCV 10 Sales YoY Growth (2021-2032) & (K Doses) Figure 11. Global Pneumococcal Bacteria Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Pneumococcal Bacteria Vaccine Market Share by Type 2025 VS 2032 Figure 13. North America Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. North America Pneumococcal Bacteria Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Europe Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Pneumococcal Bacteria Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Pneumococcal Bacteria Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Pneumococcal Bacteria Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Pneumococcal Bacteria Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Pneumococcal Bacteria Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Infant Image Figure 26. Global Infant Sales YoY Growth (2021-2032) & (K Doses) Figure 27. Children Image Figure 28. Global Children Sales YoY Growth (2021-2032) & (K Doses) Figure 29. Adult Image Figure 30. Global Adult Sales YoY Growth (2021-2032) & (K Doses) Figure 31. Global Pneumococcal Bacteria Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pneumococcal Bacteria Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Pneumococcal Bacteria Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pneumococcal Bacteria Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pneumococcal Bacteria Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pneumococcal Bacteria Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pneumococcal Bacteria Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pneumococcal Bacteria Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Pneumococcal Bacteria Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 44. North America Pneumococcal Bacteria Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pneumococcal Bacteria Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pneumococcal Bacteria Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pneumococcal Bacteria Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 48. Europe Pneumococcal Bacteria Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pneumococcal Bacteria Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pneumococcal Bacteria Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pneumococcal Bacteria Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 52. Asia-Pacific Pneumococcal Bacteria Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pneumococcal Bacteria Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pneumococcal Bacteria Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pneumococcal Bacteria Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 56. Latin America Pneumococcal Bacteria Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pneumococcal Bacteria Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pneumococcal Bacteria Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 60. Middle East and Africa Pneumococcal Bacteria Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pneumococcal Bacteria Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pneumococcal Bacteria Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pneumococcal Bacteria Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pneumococcal Bacteria Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • PPSV 23
  • PCV 13
  • PCV 10
Applications
  • Infant
  • Children
  • Adult
Companies covered
  • Sanofi
  • Merck
  • Pfizer
  • GSK
  • Walvax
  • Sinopharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pneumococcal Bacteria Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pneumococcal Bacteria Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pneumococcal Bacteria Vaccine Market by Type
  6. 1.3.1 PPSV 23
  7. 1.3.2 PCV 13
  8. 1.3.3 PCV 10
  9. 1.4 Global Pneumococcal Bacteria Vaccine Market Size by Type
  10. 1.4.1 Global Pneumococcal Bacteria Vaccine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Pneumococcal Bacteria Vaccine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Pneumococcal Bacteria Vaccine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Pneumococcal Bacteria Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Pneumococcal Bacteria Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Pneumococcal Bacteria Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Pneumococcal Bacteria Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Pneumococcal Bacteria Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pneumococcal Bacteria Vaccine Industry Trends
  2. 2.2 Pneumococcal Bacteria Vaccine Industry Drivers
  3. 2.3 Pneumococcal Bacteria Vaccine Industry Opportunities and Challenges
  4. 2.4 Pneumococcal Bacteria Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pneumococcal Bacteria Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Pneumococcal Bacteria Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Pneumococcal Bacteria Vaccine Price (2021-2026)
  4. 3.4 Global Pneumococcal Bacteria Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pneumococcal Bacteria Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Pneumococcal Bacteria Vaccine Company, Product Type & Application
  7. 3.7 Global Pneumococcal Bacteria Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pneumococcal Bacteria Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pneumococcal Bacteria Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pneumococcal Bacteria Vaccine Tier 1, Tier 2, and Tier 3
4 Pneumococcal Bacteria Vaccine Regional Status and Outlook
  1. 4.1 Global Pneumococcal Bacteria Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pneumococcal Bacteria Vaccine Historic Market Size by Region
  3. 4.2.1 Global Pneumococcal Bacteria Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pneumococcal Bacteria Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pneumococcal Bacteria Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pneumococcal Bacteria Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Pneumococcal Bacteria Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pneumococcal Bacteria Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pneumococcal Bacteria Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pneumococcal Bacteria Vaccine by Application
  1. 5.1 Pneumococcal Bacteria Vaccine Market by Application
  2. 5.1.1 Infant
  3. 5.1.2 Children
  4. 5.1.3 Adult
  5. 5.2 Global Pneumococcal Bacteria Vaccine Market Size by Application
  6. 5.2.1 Global Pneumococcal Bacteria Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pneumococcal Bacteria Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pneumococcal Bacteria Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pneumococcal Bacteria Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pneumococcal Bacteria Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pneumococcal Bacteria Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pneumococcal Bacteria Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pneumococcal Bacteria Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Pneumococcal Bacteria Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Pneumococcal Bacteria Vaccine Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Pneumococcal Bacteria Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Pneumococcal Bacteria Vaccine Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Pneumococcal Bacteria Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Pneumococcal Bacteria Vaccine Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GSK
  20. 6.4.1 GSK Company Information
  21. 6.4.2 GSK Business Overview
  22. 6.4.3 GSK Pneumococcal Bacteria Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GSK Pneumococcal Bacteria Vaccine Product Portfolio
  24. 6.4.5 GSK Recent Developments
  25. 6.5 Walvax
  26. 6.5.1 Walvax Company Information
  27. 6.5.2 Walvax Business Overview
  28. 6.5.3 Walvax Pneumococcal Bacteria Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Walvax Pneumococcal Bacteria Vaccine Product Portfolio
  30. 6.5.5 Walvax Recent Developments
  31. 6.6 Sinopharm
  32. 6.6.1 Sinopharm Company Information
  33. 6.6.2 Sinopharm Business Overview
  34. 6.6.3 Sinopharm Pneumococcal Bacteria Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sinopharm Pneumococcal Bacteria Vaccine Product Portfolio
  36. 6.6.5 Sinopharm Recent Developments
7 North America by Country
  1. 7.1 North America Pneumococcal Bacteria Vaccine Sales by Country
  2. 7.1.1 North America Pneumococcal Bacteria Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pneumococcal Bacteria Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Pneumococcal Bacteria Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pneumococcal Bacteria Vaccine Market Size by Country
  6. 7.2.1 North America Pneumococcal Bacteria Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pneumococcal Bacteria Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Pneumococcal Bacteria Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pneumococcal Bacteria Vaccine Sales by Country
  2. 8.1.1 Europe Pneumococcal Bacteria Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pneumococcal Bacteria Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Pneumococcal Bacteria Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pneumococcal Bacteria Vaccine Market Size by Country
  6. 8.2.1 Europe Pneumococcal Bacteria Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pneumococcal Bacteria Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pneumococcal Bacteria Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pneumococcal Bacteria Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Pneumococcal Bacteria Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pneumococcal Bacteria Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pneumococcal Bacteria Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pneumococcal Bacteria Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Pneumococcal Bacteria Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pneumococcal Bacteria Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pneumococcal Bacteria Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pneumococcal Bacteria Vaccine Sales by Country
  2. 10.1.1 South America Pneumococcal Bacteria Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pneumococcal Bacteria Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Pneumococcal Bacteria Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pneumococcal Bacteria Vaccine Market Size by Country
  6. 10.2.1 South America Pneumococcal Bacteria Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pneumococcal Bacteria Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Pneumococcal Bacteria Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Pneumococcal Bacteria Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pneumococcal Bacteria Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pneumococcal Bacteria Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Pneumococcal Bacteria Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pneumococcal Bacteria Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pneumococcal Bacteria Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pneumococcal Bacteria Vaccine Value Chain Analysis
  2. 12.1.1 Pneumococcal Bacteria Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pneumococcal Bacteria Vaccine Production Mode & Process
  7. 12.2 Pneumococcal Bacteria Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pneumococcal Bacteria Vaccine Distributors
  10. 12.2.3 Pneumococcal Bacteria Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst